
### [MONDO:0015949](http://purl.obolibrary.org/obo/MONDO_0015949)
**Label:** genetic subcutaneous tissue disorder

**Subclasses:** [MONDO:0019599](http://purl.obolibrary.org/obo/MONDO_0019599) (primary lipodystrophy), [MONDO:0016584](http://purl.obolibrary.org/obo/MONDO_0016584) (mandibuloacral dysplasia), [MONDO:0020087](http://purl.obolibrary.org/obo/MONDO_0020087) (genetic lipodystrophy), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0020088](http://purl.obolibrary.org/obo/MONDO_0020088) (familial partial lipodystrophy), [MONDO:0007908](http://purl.obolibrary.org/obo/MONDO_0007908) (multiple symmetric lipomatosis), [MONDO:0020089](http://purl.obolibrary.org/obo/MONDO_0020089) (acquired lipodystrophy), [MONDO:0019194](http://purl.obolibrary.org/obo/MONDO_0019194) (localized lipodystrophy), 

**Corr. equiv. classes:** [OMIM:604367](http://purl.obolibrary.org/obo/OMIM_604367), [OMIM:608600](http://purl.obolibrary.org/obo/OMIM_608600), [OMIM:608612](http://purl.obolibrary.org/obo/OMIM_608612), [OMIM:151660](http://purl.obolibrary.org/obo/OMIM_151660), [OMIM:269700](http://purl.obolibrary.org/obo/OMIM_269700), [OMIM:151800](http://purl.obolibrary.org/obo/OMIM_151800), [Orphanet:2398](http://www.orpha.net/ORDO/Orphanet_2398), [OMIM:248370](http://purl.obolibrary.org/obo/OMIM_248370), [OMIM:615238](http://purl.obolibrary.org/obo/OMIM_615238), [Orphanet:98305](http://www.orpha.net/ORDO/Orphanet_98305), [OMIM:613877](http://purl.obolibrary.org/obo/OMIM_613877), [Orphanet:528](http://www.orpha.net/ORDO/Orphanet_528), [Orphanet:79088](http://www.orpha.net/ORDO/Orphanet_79088), [Orphanet:98306](http://www.orpha.net/ORDO/Orphanet_98306), [Orphanet:98307](http://www.orpha.net/ORDO/Orphanet_98307), [OMIM:612526](http://purl.obolibrary.org/obo/OMIM_612526), [OMIM:608594](http://purl.obolibrary.org/obo/OMIM_608594), [Orphanet:90970](http://www.orpha.net/ORDO/Orphanet_90970), [Orphanet:2457](http://www.orpha.net/ORDO/Orphanet_2457), 

**Class expressions from DL-Learner:**

- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.82%
- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 76.82%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.82%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.82%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 76.32%
- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 76.32%
- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) 76.32%
- [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) 76.32%
- [HP:0001072](http://purl.obolibrary.org/obo/HP_0001072) (Thickened skin) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.32%
- [HP:0000956](http://purl.obolibrary.org/obo/HP_0000956) (Acanthosis nigricans) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.32%
- [HP:0000956](http://purl.obolibrary.org/obo/HP_0000956) (Acanthosis nigricans) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.32%
- [HP:0000819](http://purl.obolibrary.org/obo/HP_0000819) (Diabetes mellitus) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.32%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) and [HP:0003077](http://purl.obolibrary.org/obo/HP_0003077) (Hyperlipidemia) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 76.32%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) 74.94%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 74.94%


